{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:48:31Z","timestamp":1767847711835,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81072140"],"award-info":[{"award-number":["81072140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172477"],"award-info":[{"award-number":["81172477"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Committee of Science and Technology, China","award":["14ZR1443700"],"award-info":[{"award-number":["14ZR1443700"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.placenta.2014.07.012","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T23:04:17Z","timestamp":1406847857000},"page":"824-830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dysregulated activation of c-Src in gestational trophoblastic disease contributes to its aggressive progression"],"prefix":"10.1016","volume":"35","author":[{"given":"W.","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9742","key":"10.1016\/j.placenta.2014.07.012_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.placenta.2014.07.012_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.placenta.2014.07.012_bib3","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1210\/en.2012-1167","article-title":"Suppression of hydatidiform molar growth by inhibiting endogenous brain-derived neurotrophic factor\/tyrosine kinase B signaling","volume":"153","author":"Kawamura","year":"2012","journal-title":"Endocrinology"},{"issue":"16","key":"10.1016\/j.placenta.2014.07.012_bib4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMcp0900696","article-title":"Clinical practice. Molar pregnancy","volume":"360","author":"Berkowitz","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.placenta.2014.07.012_bib5","first-page":"S130","article-title":"Trophoblastic disease","volume":"119","author":"Ngan","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.placenta.2014.07.012_bib6","first-page":"110","article-title":"Prophylactic actinomycin D for high-risk complete hydatidiform mole","volume":"46","author":"Limpongsanurak","year":"2001","journal-title":"J\u00a0Reprod Med"},{"issue":"3","key":"10.1016\/j.placenta.2014.07.012_bib7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1097-0142(19860801)58:3<624::AID-CNCR2820580305>3.0.CO;2-6","article-title":"Prophylactic chemotherapy for hydatidiform mole. Five to 15 years follow-up","volume":"58","author":"Kashimura","year":"1986","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.placenta.2014.07.012_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nrc1366","article-title":"A\u00a0renaissance for SRC","volume":"4","author":"Yeatman","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.placenta.2014.07.012_bib9","first-page":"114","article-title":"Src in cancer: deregulation and consequences for cell behaviour","volume":"1602","author":"Frame","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"49","key":"10.1016\/j.placenta.2014.07.012_bib10","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","article-title":"Role of Src expression and activation in human cancer","volume":"19","author":"Irby","year":"2000","journal-title":"Oncogene"},{"issue":"56","key":"10.1016\/j.placenta.2014.07.012_bib11","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.1038\/sj.onc.1208091","article-title":"Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis","volume":"23","author":"Wei","year":"2004","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.placenta.2014.07.012_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI116200","article-title":"Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer","volume":"91","author":"Talamonti","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.placenta.2014.07.012_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1097-2765(00)80356-1","article-title":"Crystal structures of c-Src reveal features of its autoinhibitory mechanism","volume":"3","author":"Xu","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.placenta.2014.07.012_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1479-5876-6-53","article-title":"Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines","volume":"6","author":"Eustace","year":"2008","journal-title":"J\u00a0Transl Med"},{"issue":"5","key":"10.1016\/j.placenta.2014.07.012_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.clbc.2011.03.021","article-title":"Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer","volume":"11","author":"Gucalp","year":"2011","journal-title":"Clin Breast Cancer"},{"issue":"11","key":"10.1016\/j.placenta.2014.07.012_bib16","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/bjc.2012.158","article-title":"Phase I study of saracatinib (AZD0530) in combination with paclitaxel and\/or carboplatin in patients with solid tumours","volume":"106","author":"Kaye","year":"2012","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.placenta.2014.07.012_bib17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/1535-7163.MCT-08-0126","article-title":"SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells","volume":"7","author":"Vultur","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.placenta.2014.07.012_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10549-010-1302-4","article-title":"PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and\u00a0metastasis in\u00a0vitro and in\u00a0vivo","volume":"130","author":"Ma","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"10.1016\/j.placenta.2014.07.012_bib19","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1158\/1078-0432.CCR-10-0748","article-title":"Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors","volume":"16","author":"Baselga","year":"2010","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"issue":"2","key":"10.1016\/j.placenta.2014.07.012_bib20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10637-010-9611-3","article-title":"A\u00a0phase I\/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer","volume":"30","author":"Renouf","year":"2012","journal-title":"Invest New Drugs"},{"issue":"1","key":"10.1016\/j.placenta.2014.07.012_bib21","first-page":"1","article-title":"Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients","volume":"45","author":"Curry","year":"1975","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.placenta.2014.07.012_bib22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/labinvest.3780334","article-title":"Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta","volume":"81","author":"Tarrade","year":"2001","journal-title":"Lab Invest J Tech Methods Pathol"},{"key":"10.1016\/j.placenta.2014.07.012_bib23","article-title":"CCL17 induces trophoblast migration and invasion by regulating matrix metalloproteinase and integrin expression in human first-trimester placenta","author":"Li","year":"2014","journal-title":"Reprod Sci"},{"issue":"11","key":"10.1016\/j.placenta.2014.07.012_bib24","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/en.2011-1196","article-title":"Endostatin suppresses IGF-II-mediated signaling and invasion of human extravillous trophoblasts","volume":"152","author":"Pollheimer","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.placenta.2014.07.012_bib25","doi-asserted-by":"crossref","first-page":"e29920","DOI":"10.1371\/journal.pone.0029920","article-title":"Trihydrophobin 1 phosphorylation by c-Src regulates MAPK\/ERK signaling and cell migration","volume":"7","author":"Wu","year":"2012","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.placenta.2014.07.012_bib26","first-page":"765","article-title":"Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma","volume":"32","author":"Zhang","year":"2011","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.placenta.2014.07.012_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/PGP.0b013e318189555b","article-title":"P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics","volume":"28","author":"Zhang","year":"2009","journal-title":"Int J Gynecol Pathol"},{"issue":"13","key":"10.1016\/j.placenta.2014.07.012_bib28","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1074\/jbc.M806144200","article-title":"Trihydrophobin 1 interacts with PAK1 and regulates ERK\/MAPK activation and cell migration","volume":"284","author":"Cheng","year":"2009","journal-title":"J\u00a0Biol Chem"},{"issue":"Pt 15","key":"10.1016\/j.placenta.2014.07.012_bib29","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1242\/jcs.03055","article-title":"Identification of SRC as a key PKA-stimulated tyrosine kinase involved in the capacitation-associated hyperactivation of murine spermatozoa","volume":"119","author":"Baker","year":"2006","journal-title":"J\u00a0Cell Sci"},{"issue":"Pt 25","key":"10.1016\/j.placenta.2014.07.012_bib30","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1242\/jcs.01527","article-title":"PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells","volume":"117","author":"Obara","year":"2004","journal-title":"J\u00a0Cell Sci"},{"issue":"8","key":"10.1016\/j.placenta.2014.07.012_bib31","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1073\/pnas.1018861108","article-title":"Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis","volume":"109","author":"Marcotte","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.placenta.2014.07.012_bib32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/abbs\/gmt042","article-title":"c-Src regulates cell cycle proteins expression through protein kinase B\/glycogen synthase kinase 3 beta and extracellular signal-regulated kinases 1\/2 pathways in MCF-7 cells","volume":"45","author":"Liu","year":"2013","journal-title":"Acta Biochim Biophys Sin"},{"issue":"5","key":"10.1016\/j.placenta.2014.07.012_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"10.1016\/j.placenta.2014.07.012_bib34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1083\/jcb.200701133","article-title":"Src kinase activity and SH2 domain regulate the dynamics of Src association with lipid and protein targets","volume":"178","author":"Shvartsman","year":"2007","journal-title":"J\u00a0Cell Biol"},{"issue":"2","key":"10.1016\/j.placenta.2014.07.012_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1083\/jcb.145.2.377","article-title":"Dual fatty acylation of p59(Fyn) is required for association with the T cell receptor zeta chain through phosphotyrosine-Src homology domain-2 interactions","volume":"145","author":"van't Hof","year":"1999","journal-title":"J\u00a0Cell Biol"},{"issue":"6","key":"10.1016\/j.placenta.2014.07.012_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0959-440X(97)80146-7","article-title":"Structures of Src-family tyrosine kinases","volume":"7","author":"Sicheri","year":"1997","journal-title":"Curr Opin Struct Biol"},{"issue":"48","key":"10.1016\/j.placenta.2014.07.012_bib37","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1038\/sj.onc.1208079","article-title":"The interplay between Src family kinases and receptor tyrosine kinases","volume":"23","author":"Bromann","year":"2004","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.placenta.2014.07.012_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2004.09.001","article-title":"c-Src and cooperating partners in human cancer","volume":"6","author":"Ishizawar","year":"2004","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.placenta.2014.07.012_bib39","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/j.1460-2075.1996.tb00471.x","article-title":"Tyrosine kinase\/p21ras\/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells","volume":"15","author":"Migliaccio","year":"1996","journal-title":"Embo J"},{"issue":"2","key":"10.1016\/j.placenta.2014.07.012_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2006.11.049","article-title":"p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2","volume":"128","author":"Chu","year":"2007","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.placenta.2014.07.012_bib41","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2353\/ajpath.2008.080288","article-title":"Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome","volume":"173","author":"Siu","year":"2008","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.placenta.2014.07.012_bib42","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1038\/ncb0402-e97","article-title":"Adhesion assembly, disassembly and turnover in migrating cells \u2013 over and over and over again","volume":"4","author":"Webb","year":"2002","journal-title":"Nat Cell Biol"},{"issue":"5","key":"10.1016\/j.placenta.2014.07.012_bib43","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ceb.2005.08.007","article-title":"Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition","volume":"17","author":"Avizienyte","year":"2005","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"10.1016\/j.placenta.2014.07.012_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ncb1094","article-title":"FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly","volume":"6","author":"Webb","year":"2004","journal-title":"Nat Cell Biol"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400414006390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400414006390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:50:06Z","timestamp":1758909006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400414006390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0143400414006390"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2014.07.012","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated activation of c-Src in gestational trophoblastic disease contributes to its aggressive progression","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2014.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}